title: Liver transplantation in children: the experience of Queen Mary Hospital, Hong Kong.
abstract: Seven living-related liver transplants (LRLT) and two reduced-size liver transplants (RSLT) were performed on eight children who suffered from end-stage liver disease, having previously undergone one to three abdominal operations. Their ages at initial transplantation ranged from 8 months to 11 years (mean 35 months, median 12 months). Excluding the two older children aged 7 and 11 years, respectively, the rest of the children weighed 6 to 9.5 kg (mean 7.3 kg) at the time of the initial transplantation. Seven left lateral segments (S2 + 3) and two left lobes (S2 + 3 + 4) were used; of these the smallest graft had a graft-to-recipient body weight ratio of 0.9%. The volunteer living donors were four mothers, two fathers and one sister who were selected after medical and psychiatric evaluations, and their suitability was confirmed by hematological, biochemical, and radiological criteria. During a follow-up period of 3 to 30 months, all eight children are alive and well with normal liver function, one of them having undergone a retransplant LRLT because of hepatitis of undetermined etiology following a RSLT 1.5 years earlier. All seven donors had an uneventful postoperative course and were discharged on day 4 to 7 postoperatively. They have all resumed normal day-to-day activities. There were no complications in the donor group. A variety of complications occurred in the recipients, all of which were overcome. Operating microscope was used to perform all the arterial anastomoses using microvascular techniques. This method has proven to be a major factor in preventing arterial thrombosis even with the smallest of arterial anastomosis where a 1.5-mm diameter recipient artery was anastomosed to a 2.5-mm diameter donor hepatic artery.
authors.affiliation: Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong.
authors.forename: H
authors.initials: H
authors.lastname: Saing
authors.forename: S T
authors.initials: ST
authors.lastname: Fan
authors.forename: K L
authors.initials: KL
authors.lastname: Chan
authors.forename: W I
authors.initials: WI
authors.lastname: Wei
authors.forename: C M
authors.initials: CM
authors.lastname: Lo
authors.forename: G H
authors.initials: GH
authors.lastname: Mya
authors.forename: N S
authors.initials: NS
authors.lastname: Tsoi
authors.forename: K Y
authors.initials: KY
authors.lastname: Yuen
authors.forename: I O
authors.initials: IO
authors.lastname: Ng
authors.forename: J W
authors.initials: JW
authors.lastname: Lo
authors.forename: M T
authors.initials: MT
authors.lastname: Chau
authors.forename: W K
authors.initials: WK
authors.lastname: Tsoi
authors.forename: J
authors.initials: J
authors.lastname: Chan
authors.forename: J
authors.initials: J
authors.lastname: Wong
mesh_terms: D000203:Activities of Daily Living; D000714:Anastomosis, Surgical / Q000379:methods; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006499:Hepatic Artery / Q000601:surgery; D006505:Hepatitis / Q000601:surgery; D006648:Histocompatibility; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D007223:Infant; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods / Q000473:pathology / Q000706:statistics & numerical data*; D019520:Living Donors / Q000145:classification; D008297:Male; D008866:Microsurgery; D009929:Organ Size; D011183:Postoperative Complications / Q000517:prevention & control / Q000601:surgery; D012086:Reoperation; D015996:Survival Rate; D013927:Thrombosis / Q000517:prevention & control; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000379:methods